Citations

Clear

349 citation(s) found for "Sarkaria, Jann N".

CADD-48. microRNA-34a PACKAGED IN BACTERIAL NANOCELLS OVERCOMES THERAPEUTIC RESISTANCE IN GLIOBLASTOMA
Khan, Muhammad Babar , Ruggieri, Rosamaria, MacDiarmid, Jennifer A. , Brahmbhatt, Himanshu , Boockvar, John A. , Symons, Marc , Tran, Nhan L. , Sarkaria, Jann N.

Mayo Clinic

Neuro-Oncology | November 5, 2018 | Volume: 20 | Issue: suppl_6 | Pages: vi282-vi282

10.1093/neuonc/noy148.1176 Get It

RTHP-02. IMPACT OF 18F-DOPA PET ON RADIOTHERAPY TARGET VOLUMES FOR NEWLY DIAGNOSED MGMT UNMETHYLATED GLIOBLASTOMA PATIENTS; PRELIMINARY RESULTS OF A PHASE II DOSE-ESCALATION TRIAL
Brinkmann, Debra H. , Pafundi, Deanna, Lowe, Val J. , Yan, Elizabeth , Brown, Paul D. , Zakhary, Mark J. , Seaberg, Maasa , Tseung, Hok Seum Wan Chan, Hunt, Christopher H. , Zhang, Yan, Sarkaria, Jann N. , Laack, Nadia N.

Mayo Clinic

Neuro-Oncology | November 5, 2018 | Volume: 20 | Issue: suppl_6 | Pages: vi225-vi225

10.1093/neuonc/noy148.934 Get It

RDNA-06. A NOVEL ROLE OF SGEF IN MEDIATING GBM CELL SURVIVAL BY MODULATING THE DNA DAMAGE REPAIR MECHANISM
Tuncali, Serdar, Sereduk, Christopher, Ensign, Shannon P. Fortin , Kloss, Jean , Loftus, Joseph C. , Ensign, Shannon P. Fortin , Sereduk, Chris , Sarkaria, Jann N. , Tran, Nhan L.

Mayo Clinic

Neuro-Oncology | November 5, 2018 | Volume: 20 | Issue: suppl_6 | Pages: vi222-vi223

10.1093/neuonc/noy148.922 Get It

DDIS-01. THE ANTIBODY-DRUG CONJUGATE ABT-414 DEMONSTRATES SINGLE-AGENT ANTI-CANCER ACTIVITY ACROSS A PANEL OF GBM PATIENT-DERIVED XENOGRAFTS
Marin, Bianca M. , Hu, Zeng, Carlson, Brett L. , Marin, Bianca M , Mladek, Ann C. , Burgenske, Danielle M. , He, Lihong , Bakken, Katrina K. , Schroeder, Mark A. , Sarkaria, Jann N.

Mayo Clinic

Neuro-Oncology | November 5, 2018 | Volume: 20 | Issue: suppl_6 | Pages: vi69-vi69

10.1093/neuonc/noy148.280 Get It

CADD-57. THE EFFICACY OF THERAPY WITH ABT-414, AN EGFR-TARGETING ADC, IS POTENTIALLY ALTERED BY HETEROZYGOUS DELETION OF THE ENDOCYTIC TRAFFICKING REGULATOR RBSN
Muller-Greven, Gaëlle, Marin, Bianca M. , Carlin, Cathleen R. , Reilly, Edward B. , Bredel, M., Gladson, Candece L. , Marin, Bianca M , Müller-Greven, Gaëlle, Lee, Jeongwu , Sarkaria, Jann N.

Mayo Clinic

Neuro-Oncology | November 5, 2018 | Volume: 20 | Issue: suppl_6 | Pages: vi283-vi284

10.1093/neuonc/noy148.1182 Get It

RDNA-04. POTENTIAL MECHANISM OF TEMOZOLOMIDE-MEDIATED RADIO-SENSITIZATION IN MGMT HYPERMETHYLATED GLIOBLASTOMA CELLS
Kitange, Gaspar J. , Smith, Emily, Gupta, Shiv K. , Sarkaria, Jann N.

Mayo Clinic

Neuro-Oncology | November 5, 2018 | Volume: 20 | Issue: suppl_6 | Pages: vi222-vi222

10.1093/neuonc/noy148.920 Get It

DRES-17. ACTIVATION OF FGF SIGNALING PATHWAY CONFERS RESISTANCE TO EGFR INHIBITION IN GBM
Gong, Ke , Habib, Amyn A. , Guo, Gao , Sarkaria, Jann N.

Mayo Clinic

Neuro-Oncology | November 5, 2018 | Volume: 20 | Issue: suppl_6 | Pages: vi79-vi79

10.1093/neuonc/noy148.324 Get It

TMOD-11. IMAGING BASED INVASION METRIC PREDICTIVE OF RESPONSE TO ABT414 IN ORTHOTOPIC EGFRviii AMPLIFIED PATIENT DERIVED XENOGRAFTS
Marin, Bianca M. , Paulson, Lisa, Kasle, Lauren, Jackson, Pamela , Marin, Bianca M , Massey, Susan Christine , Hawkins‐Daarud, Andrea , Mladek, Ann C. , Sarkaria, Jann N. , Swanson, Kristin R

Mayo Clinic

Neuro-Oncology | November 5, 2018 | Volume: 20 | Issue: suppl_6 | Pages: vi270-vi271

10.1093/neuonc/noy148.1124 Get It

TMIC-36. LOCAL TISSUE BIOMARKERS OF RESPONSE TO THERAPY FOR GLIOBLASTOMA
Olson, Ian , Jacobs, Joshua , Rajani, Karishma , Macura, Slobodan , Sarkaria, Jann N. , Burns, Terry C.

Mayo Clinic

Neuro-Oncology | November 5, 2018 | Volume: 20 | Issue: suppl_6 | Pages: vi264-vi264

10.1093/neuonc/noy148.1095 Get It

DDIS-25. TARGETING GLIOBLASTOMA HETEROGENEITY WITH miR-34a
Khan, Muhammad Babar , Ruggieri, Rosamaria, MacDiarmid, Jennifer A. , Brahmbhatt, Himanshu , Boockvar, John A. , Symons, Marc , Tran, Nhan L. , Sarkaria, Jann N.

Mayo Clinic

Neuro-Oncology | November 5, 2018 | Volume: 20 | Issue: suppl_6 | Pages: vi74-vi74

10.1093/neuonc/noy148.304 Get It